Skip to content

Clinical trials

Intermittent Claudication trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intermittent Claudication Phase: Not applicable Clear all

145 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20032
20043
20052
20063
20071
20081
20093
20106
201110
20122
20137
201413
201510
20165
201710
201810
20196
20202
202112
20229
20239
20247
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed84
Unknown status26
Recruiting19
Terminated5
Withdrawn4
Not yet recruiting4
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medtronic Endovascular5
Sahlgrenska University Hospital5
Abbott Medical Devices4
Hull University Teaching Hospitals NHS Trust4
Imperial College London4
University of Oklahoma4
KU Leuven3
Oslo University Hospital3
Philips Clinical & Medical Affairs Global3
University of Minnesota3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intermittent Claudication145
Peripheral Arterial Disease95
Peripheral Vascular Diseases24
Chronic Limb-Threatening Ischemia13
Atherosclerosis9
Vascular Diseases9
Cardiovascular Diseases8
Agnosia3
Arterial Occlusive Diseases3
Spinal Stenosis3

Trials

Showing 26 to 50 of 145. Each trial links to its page on Pharma Observatory.

45 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.